Basilea Pharma awarded USD 7.3 million additional CARB-X funding to develop new drug candidate from a novel class of antibiotics: Allschwil, Switzerland Thursday, December 26, 202 ...
“While we are waiting for approvals, we have also moved on. We shall be unveiling new products in 2025,” he said. The NNMDA director general acknowledged the challenges that antimicrobial resistance ...
The Nigerian Natural Medicine Development Agency (NNMDA) is making significant progress towards developing solutions to combat cholera outbreaks in Nigeria with natural medicine, it emerged on Tuesday ...
The competition landscape of the synbiotic animal feed market is intense. Cargill (Purina), Vetafarm, and Protexin Veterninary are the major market players and contribute significantly in terms of ...